{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T01:36:30Z","timestamp":1792373790545,"version":"4.4.0"},"reference-count":90,"publisher":"Elsevier BV","issue":"25","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T00:00:00Z","timestamp":1750809600000},"content-version":"vor","delay-in-days":389,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jacc.2024.03.431","type":"journal-article","created":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T18:31:13Z","timestamp":1718649073000},"page":"2674-2689","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Intravenous Iron Repletion for Patients With Heart\u00a0Failure and Iron Deficiency"],"prefix":"10.1016","volume":"83","author":[{"given":"Baljash","family":"Cheema","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3102-2371","authenticated-orcid":false,"given":"Anuj","family":"Chokshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olusola","family":"Orimoloye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Ardehali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2024.03.431_bib1","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1161\/CIRCULATIONAHA.118.030099","article-title":"Anemia and iron deficiency in heart failure: current concepts and emerging therapies","volume":"138","author":"Anand","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.03.431_bib2","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ahj.2013.01.017","article-title":"Iron deficiency in chronic heart failure: an international pooled analysis","volume":"165","author":"Klip","year":"2013","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2024.03.431_bib3","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s00392-016-1073-y","article-title":"Prevalence and clinical impact of iron deficiency and anaemia among outpatients with chronic heart failure: the PrEP registry","volume":"106","author":"von Haehling","year":"2017","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.jacc.2024.03.431_bib4","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.004519","article-title":"Definition of iron deficiency based on the gold standard of bone marrow iron staining in heart failure patients","volume":"11","author":"Grote Beverborg","year":"2018","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2024.03.431_bib5","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1016\/j.jacc.2006.08.034","article-title":"Etiology of anemia in patients with advanced heart failure","volume":"48","author":"Nanas","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.03.431_bib6","doi-asserted-by":"crossref","DOI":"10.5402\/2012\/246915","article-title":"Anemia in heart failure patients","volume":"2012","author":"Alexandrakis","year":"2012","journal-title":"ISRN Hematol"},{"key":"10.1016\/j.jacc.2024.03.431_bib7","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1159\/000361040","article-title":"Iron deficiency in heart failure","volume":"128","author":"Anand","year":"2014","journal-title":"Cardiology"},{"key":"10.1016\/j.jacc.2024.03.431_bib8","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/eurheartj\/ehs377","article-title":"Iron status in patients with chronic heart failure","volume":"34","author":"Jankowska","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.03.431_bib9","first-page":"300","article-title":"Iron and heart failure: diagnosis, therapies, and future directions","volume":"5","author":"Ghafourian","year":"2020","journal-title":"J\u00a0Am Coll Cardiol Basic Trans Science"},{"key":"10.1016\/j.jacc.2024.03.431_bib10","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1161\/CIRCRESAHA.122.321667","article-title":"Iron metabolism in cardiovascular disease: physiology, mechanisms, and therapeutic targets","volume":"132","author":"Sawicki","year":"2023","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2024.03.431_bib11","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1093\/eurheartj\/ehq158","article-title":"Iron deficiency: an ominous sign in patients with systolic chronic heart failure","volume":"31","author":"Jankowska","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.03.431_bib12","first-page":"36","article-title":"Iron deficiency in heart failure: an overview","volume":"7","author":"von Haehling","year":"2019","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jacc.2024.03.431_bib13","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ijcard.2014.03.169","article-title":"Iron deficiency and health-related quality of life in chronic heart failure: results from a multicenter European study","volume":"174","author":"Enjuanes","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2024.03.431_bib14","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.cardfail.2011.08.003","article-title":"Iron deficiency predicts impaired exercise capacity in patients with systolic chronic heart failure","volume":"17","author":"Jankowska","year":"2011","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.jacc.2024.03.431_bib15","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/00015385.2017.1351239","article-title":"Impact of iron deficiency on exercise capacity and outcome in heart failure with reduced, mid-range and preserved ejection fraction","volume":"73","author":"Martens","year":"2018","journal-title":"Acta Cardiol"},{"key":"10.1016\/j.jacc.2024.03.431_bib16","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","article-title":"Ferric carboxymaltose in patients with heart failure and iron deficiency","volume":"361","author":"Anker","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2024.03.431_bib17","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.jacc.2006.07.015","article-title":"Intravenous iron alone for the treatment of anemia in patients with chronic heart failure","volume":"48","author":"Bolger","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.03.431_bib18","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jacc.2007.09.036","article-title":"Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial","volume":"51","author":"Okonko","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.03.431_bib19","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/eurheartj\/ehu385","article-title":"Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency","volume":"36","author":"Ponikowski","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.03.431_bib20","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.jacc.2007.07.029","article-title":"Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency","volume":"50","author":"Toblli","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.03.431_bib21","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1161\/CIRCULATIONAHA.117.027497","article-title":"Effect of ferric carboxymaltose on exercise capacity in patients with chronic heart failure and iron deficiency","volume":"136","author":"van Veldhuisen","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.03.431_bib22","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/ejhf.473","article-title":"Effects of intravenous iron therapy in iron-deficient patients with systolic heart failure: a meta-analysis of randomized controlled trials","volume":"18","author":"Jankowska","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2024.03.431_bib23","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/ejhf.823","article-title":"Effects of ferric carboxymaltose on hospitalisations and mortality rates in iron-deficient heart failure patients: an individual patient data meta-analysis","volume":"20","author":"Anker","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2024.03.431_bib24","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.03.431_bib25","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.03.431_bib26","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","article-title":"2023 Focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"44","author":"McDonagh","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.03.431_bib27","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/S0140-6736(20)32339-4","article-title":"Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial","volume":"396","author":"Ponikowski","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.03.431_bib28","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1016\/S0140-6736(22)02083-9","article-title":"Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial","volume":"400","author":"Kalra","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.03.431_bib29","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa2304968","article-title":"Ferric carboxymaltose in heart failure with iron deficiency","volume":"389","author":"Mentz","year":"2023","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2024.03.431_bib30","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.2215\/CJN.01490506","article-title":"Assessing iron status: beyond serum ferritin and transferrin saturation","volume":"1","author":"Wish","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jacc.2024.03.431_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2020.100873","article-title":"Iron deficiency and supplementation in heart failure and chronic kidney disease","volume":"75","author":"Punj","year":"2020","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.jacc.2024.03.431_bib33","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1021\/cb300323q","article-title":"The ubiquity of iron","volume":"7","author":"Frey","year":"2012","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.jacc.2024.03.431_bib34","article-title":"Role of heme in cardiovascular physiology and disease","volume":"4","author":"Sawicki","year":"2015","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2024.03.431_bib35","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0092-8674(04)00343-5","article-title":"Balancing acts: molecular control of mammalian iron metabolism","volume":"117","author":"Hentze","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.jacc.2024.03.431_bib36","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1056\/NEJM199912233412607","article-title":"Disorders of iron metabolism","volume":"341","author":"Andrews","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2024.03.431_bib37","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/nri3863","article-title":"Iron homeostasis in host defence and inflammation","volume":"15","author":"Ganz","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jacc.2024.03.431_bib38","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nrd.2016.248","article-title":"Targeting iron metabolism in drug discovery and delivery","volume":"16","author":"Crielaard","year":"2017","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jacc.2024.03.431_bib39","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.tox.2011.03.001","article-title":"Advances in metal-induced oxidative stress and human disease","volume":"283","author":"Jomova","year":"2011","journal-title":"Toxicology"},{"key":"10.1016\/j.jacc.2024.03.431_bib40","first-page":"164","article-title":"Review on iron and its importance for human health","volume":"19","author":"Abbaspour","year":"2014","journal-title":"J\u00a0Res Med Sci"},{"key":"10.1016\/j.jacc.2024.03.431_bib41","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S1097-2765(02)00710-4","article-title":"An iron delivery pathway mediated by a lipocalin","volume":"10","author":"Yang","year":"2002","journal-title":"Mol Cell"},{"key":"10.1016\/j.jacc.2024.03.431_bib42","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.2215\/CJN.05931108","article-title":"Hepcidin\u2014a potential novel biomarker for iron status in chronic kidney disease","volume":"4","author":"Zaritsky","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"11","key":"10.1016\/j.jacc.2024.03.431_bib43","doi-asserted-by":"crossref","first-page":"e148671","DOI":"10.1172\/JCI148671","article-title":"Ironing out mechanisms of iron homeostasis and disorders of iron deficiency","volume":"131","author":"Koleini","year":"2021","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacc.2024.03.431_bib44","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.cmet.2012.10.001","article-title":"mTOR regulates cellular iron homeostasis through tristetraprolin","volume":"16","author":"Bayeva","year":"2012","journal-title":"Cell Metab"},{"key":"10.1016\/j.jacc.2024.03.431_bib45","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1172\/JCI88574","article-title":"Sirtuin 2 regulates cellular iron homeostasis via deacetylation of transcription factor NRF2","volume":"127","author":"Yang","year":"2017","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jacc.2024.03.431_bib46","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0140-6736(15)60865-0","article-title":"Iron deficiency anaemia","volume":"387","author":"Lopez","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2024.03.431_bib47","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJMra041809","article-title":"Anemia of chronic disease","volume":"352","author":"Weiss","year":"2005","journal-title":"N\u00a0Engle J Med"},{"key":"10.1016\/j.jacc.2024.03.431_bib48","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1161\/01.CIR.103.16.2055","article-title":"Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone Trial (VEST)","volume":"103","author":"Deswal","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.03.431_bib49","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cardfail.2007.09.006","article-title":"Cytokines and myocardial dysfunction: state of the art","volume":"14","author":"El-Menyar","year":"2008","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.jacc.2024.03.431_bib50","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.cardiores.2006.01.013","article-title":"Autonomic imbalance and immune activation in chronic heart failure\u2014pathophysiological links","volume":"70","author":"Jankowska","year":"2006","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacc.2024.03.431_bib51","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s11897-008-0012-2","article-title":"Immune modulation: role of the inflammatory cytokine cascade in the failing human heart","volume":"5","author":"Satoh","year":"2008","journal-title":"Curr Heart Fail Rep"},{"key":"10.1016\/j.jacc.2024.03.431_bib52","doi-asserted-by":"crossref","first-page":"S182","DOI":"10.1016\/S0272-6386(01)70008-X","article-title":"NKF-K\/DOQI clinical practice guidelines for anemia of chronic kidney disease: update 2000","volume":"37","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jacc.2024.03.431_bib53","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/ejhf.2251","article-title":"Natural history and prognostic significance of iron deficiency and anaemia in ambulatory patients with chronic heart failure","volume":"24","author":"Graham","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2024.03.431_bib54","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/S0735-1097(00)00613-6","article-title":"The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations","volume":"35","author":"Silverberg","year":"2000","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.03.431_bib55","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1093\/eurheartj\/ehm328","article-title":"Randomized, double-blind, placebo-controlled study to evaluate the effect of two dosing regimens of darbepoetin alfa in patients with heart failure and anaemia","volume":"28","author":"van Veldhuisen","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.03.431_bib56","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1056\/NEJMoa1214865","article-title":"Treatment of anemia with darbepoetin alfa in systolic heart failure","volume":"368","author":"Swedberg","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2024.03.431_bib57","first-page":"236","article-title":"Intravenous iron without erythropoietin for the treatment of iron deficiency anemia in patients with moderate to severe congestive heart failure and chronic kidney insufficiency","volume":"21","author":"Usmanov","year":"2008","journal-title":"J\u00a0Nephrol"},{"key":"10.1016\/j.jacc.2024.03.431_bib58","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/eurheartj\/ehs104","volume":"33","author":"McMurray","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.03.431_bib59","doi-asserted-by":"crossref","first-page":"405","DOI":"10.5694\/j.1326-5377.2011.tb03031.x","article-title":"2011 update to National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand Guidelines for the prevention, detection and management of chronic heart failure in Australia, 2006","volume":"194","author":"Krum","year":"2011","journal-title":"Med J Aust"},{"key":"10.1016\/j.jacc.2024.03.431_bib60","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1016\/j.jacc.2016.09.936","article-title":"Natriuretic peptides, 6-min walk test, and quality-of-life questionnaires as clinically meaningful endpoints in HF trials","volume":"68","author":"Ferreira","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.03.431_bib61","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.03.431_bib62","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jacc.2017.04.025","volume":"70","author":"Yancy","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.03.431_bib63","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1056\/NEJMe2308305","article-title":"Treating iron deficiency in heart failure","volume":"389","author":"Martens","year":"2023","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2024.03.431_bib64","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/ejhf.2810","article-title":"Intravenous iron in patients with heart failure and iron deficiency: an updated meta-analysis","volume":"25","author":"Graham","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2024.03.431_bib65","doi-asserted-by":"crossref","first-page":"5077","DOI":"10.1093\/eurheartj\/ehad586","article-title":"Efficacy of ferric carboxymaltose in heart failure with iron deficiency: an individual patient data meta-analysis","volume":"44","author":"Ponikowski","year":"2023","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.jacc.2024.03.431_bib66","first-page":"525","article-title":"Meta-analysis and metaregression of the treatment effect of intravenous iron in iron-deficient heart failure","volume":"12","author":"Martens","year":"2024","journal-title":"J\u00a0Am Coll Cardiol HF"},{"issue":"suppl 1","key":"10.1016\/j.jacc.2024.03.431_bib67","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1365-2362.2002.0320s1009.x","article-title":"Ferric saccharate induces oxygen radical stress and endothelial dysfunction in\u00a0vivo","volume":"32","author":"Rooyakkers","year":"2002","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jacc.2024.03.431_bib68","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.bbagen.2011.07.014","article-title":"Non-transferrin bound iron: a key role in iron overload and iron toxicity","volume":"1820","author":"Brissot","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jacc.2024.03.431_bib69","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/sj.ki.5000046","article-title":"Iron sucrose augments homocysteine-induced endothelial dysfunction in normal subjects","volume":"69","author":"Zheng","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.jacc.2024.03.431_bib70","doi-asserted-by":"crossref","first-page":"18792","DOI":"10.1002\/jcp.28518","article-title":"Iron-load exacerbates the severity of atherosclerosis via inducing inflammation and enhancing the glycolysis in macrophages","volume":"234","author":"Hu","year":"2019","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.jacc.2024.03.431_bib71","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1161\/01.CIR.99.9.1222","article-title":"Iron-deficient diet reduces atherosclerotic lesions in apoE-deficient mice","volume":"99","author":"Lee","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.03.431_bib72","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.33935","article-title":"Risk of infection associated with administration of intravenous iron: a systematic review and meta-analysis","volume":"4","author":"Shah","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jacc.2024.03.431_bib73","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/468675","article-title":"Intravenous iron administration and hypophosphatemia in clinical practice","volume":"2015","author":"Hardy","year":"2015","journal-title":"Int J Rheumatol"},{"key":"10.1016\/j.jacc.2024.03.431_bib74","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.2169\/internalmedicine.51.7450","article-title":"Fibroblast growth factor 23-related osteomalacia caused by the prolonged administration of saccharated ferric oxide","volume":"51","author":"Yamamoto","year":"2012","journal-title":"Intern Med"},{"key":"10.1016\/j.jacc.2024.03.431_bib75","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/MNH.0000000000000329","article-title":"Iron-induced hypophosphatemia: an emerging complication","volume":"26","author":"Zoller","year":"2017","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"23","key":"10.1016\/j.jacc.2024.03.431_bib76","doi-asserted-by":"crossref","first-page":"e124486","DOI":"10.1172\/jci.insight.124486","article-title":"Randomized trial of intravenous iron-induced hypophosphatemia","volume":"3","author":"Wolf","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.jacc.2024.03.431_bib77","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1046\/j.1523-1755.1999.055Suppl.69131.x","volume":"55","author":"Weinberg","year":"1999","journal-title":"Iron therapy and cancer. Kidney Int Suppl"},{"key":"10.1016\/j.jacc.2024.03.431_bib78","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1016\/j.ijcard.2013.04.181","article-title":"IRON-HF study: a randomized trial to assess the effects of iron in heart failure patients with anemia","volume":"168","author":"Beck-da-Silva","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2024.03.431_bib79","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1001\/jama.2017.5427","article-title":"Effect of oral iron repletion on exercise capacity in patients with heart failure with reduced ejection fraction and iron deficiency: the IRONOUT HF randomized clinical trial","volume":"317","author":"Lewis","year":"2017","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jacc.2024.03.431_bib80","doi-asserted-by":"crossref","first-page":"81","DOI":"10.5334\/gh.1151","article-title":"Oral ferrous sulphate improves functional capacity on heart failure patients with iron deficiency anemia","volume":"17","author":"Suryani","year":"2022","journal-title":"Glob Heart"},{"key":"10.1016\/j.jacc.2024.03.431_bib81","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ijcard.2014.10.006","article-title":"Bone marrow iron depletion is common in patients with coronary artery disease","volume":"182","author":"Jankowska","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2024.03.431_bib82","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.1002\/art.30623","article-title":"Hepcidin and hemoglobin content parameters in the diagnosis of iron deficiency in rheumatoid arthritis patients with anemia","volume":"63","author":"van Santen","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jacc.2024.03.431_bib83","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1093\/eurheartj\/ehu235","article-title":"Iron deficiency defined as depleted iron stores accompanied by unmet cellular iron requirements identifies patients at the highest risk of death after an episode of acute heart failure","volume":"35","author":"Jankowska","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.03.431_bib84","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1161\/CIRCULATIONAHA.122.060511","article-title":"Iron deficiency in heart failure and effect of dapagliflozin: findings from DAPA-HF","volume":"146","author":"Docherty","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.03.431_bib85","first-page":"1611","article-title":"Short-term changes in peak VO(2) after initiation of dapagliflozin in heart failure across iron status","volume":"11","author":"Lorenzo","year":"2023","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jacc.2024.03.431_bib86","article-title":"Noninvasive imaging estimation of myocardial iron repletion following administration of intravenous iron: the Myocardial\u2013IRON trial","volume":"9","author":"N\u00fa\u00f1ez","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.03.431_bib87","first-page":"106","article-title":"Potential interactions when prescribing SGLT2 inhibitors and intravenous iron in combination in heart failure","volume":"11","author":"Packer","year":"2023","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jacc.2024.03.431_bib88","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/ejhf.2092","article-title":"Oral sucrosomial iron improves exercise capacity and quality of life in heart failure with\u00a0reduced ejection fraction and iron deficiency: a non-randomized, open-label, proof-of-concept study","volume":"23","author":"Karavidas","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2024.03.431_bib89","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1182\/hematology.2019000034","article-title":"Management of iron deficiency","volume":"2019","author":"Ning","year":"2019","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jacc.2024.03.431_bib90","doi-asserted-by":"crossref","first-page":"e524","DOI":"10.1016\/S2352-3026(17)30182-5","article-title":"Iron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron-depleted women: two open-label, randomised controlled trials","volume":"4","author":"Stoffel","year":"2017","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jacc.2024.03.431_bib91","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jacc.2021.11.039","article-title":"Criteria for iron deficiency in patients with heart failure","volume":"79","author":"Masini","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109724070323?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109724070323?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T00:22:56Z","timestamp":1750810976000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109724070323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":90,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S0735109724070323"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2024.03.431","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravenous Iron Repletion for Patients With Heart\u00a0Failure and Iron Deficiency","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2024.03.431","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}